QQQ   418.20 (-1.23%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   418.20 (-1.23%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   418.20 (-1.23%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
QQQ   418.20 (-1.23%)
AAPL   164.95 (-1.25%)
MSFT   401.13 (-0.78%)
META   487.97 (-2.76%)
GOOGL   154.75 (-0.81%)
AMZN   176.23 (-1.67%)
TSLA   149.30 (-0.42%)
NVDA   817.98 (-3.39%)
AMD   148.63 (-4.16%)
NIO   3.83 (-4.25%)
BABA   68.70 (-0.26%)
T   16.35 (+0.12%)
F   12.12 (+0.50%)
MU   107.54 (-3.92%)
GE   149.23 (-2.43%)
CGC   7.95 (+1.53%)
DIS   111.64 (-0.70%)
AMC   3.19 (+9.25%)
PFE   25.82 (+1.69%)
PYPL   61.95 (-0.24%)
XOM   120.16 (+1.38%)
Free Trial

Edwards Lifesciences (EW) Earnings Date, Estimates & Call Transcripts

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)
Free EW Stock Alerts
$85.64
-0.81 (-0.94%)
(As of 11:58 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Apr. 25
After Market Closes
Confirmed
Actual EPS
(Feb. 6)
$0.64
Consensus EPS
(Feb. 6)
$0.64
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

EW Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

EW Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Edwards Lifesciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$0.64$0.65$0.640.620 - 0.660
Q2 20243$0.70$0.71$0.70 
Q3 20243$0.68$0.70$0.69 
Q4 20243$0.70$0.73$0.72 
FY 202412$2.72$2.79$2.75 
Q1 20253$0.74$0.77$0.75 
Q2 20253$0.77$0.79$0.78 
Q3 20253$0.76$0.79$0.77 
Q4 20253$0.77$0.80$0.79 
FY 202512$3.04$3.15 $3.10

EW Earnings Date and Information

Edwards Lifesciences last issued its earnings results on February 6th, 2024. The medical research company reported $0.64 earnings per share for the quarter, hitting analysts' consensus estimates of $0.64. The firm earned $1.53 billion during the quarter, compared to analyst estimates of $1.50 billion. Its revenue for the quarter was up 13.3% compared to the same quarter last year. Edwards Lifesciences has generated $2.30 earnings per share over the last year ($2.30 diluted earnings per share) and currently has a price-to-earnings ratio of 37.6. Earnings for Edwards Lifesciences are expected to grow by 12.32% in the coming year, from $2.76 to $3.10 per share. Edwards Lifesciences has confirmed that its next quarterly earnings report will be published on Thursday, April 25th, 2024. Edwards Lifesciences will be holding an earnings conference call on Thursday, April 25th at 5:00 PM Eastern. Interested parties can register for or listen to the call..

Edwards Lifesciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
4/25/2024
Confirmed)		-------  
2/6/2024Q4 2023$0.64$0.64-$0.67$1.50 billion$1.53 billion    
10/25/2023Q3 2023$0.59$0.59-$0.55$1.48 billion$1.48 billion      
7/26/2023Q2 2023$0.65$0.66+$0.01$0.82$1.51 billion$1.53 billion    
4/26/2023Q1 2023$0.61$0.62+$0.01$0.68$1.39 billion$1.46 billion      
1/31/2023Q4 2022$0.61$0.64+$0.03$0.63$1.33 billion$1.35 billion    
10/27/2022Q3 2022$0.62$0.61($0.01)$0.67$1.34 billion$1.32 billion
7/28/2022Q2 2022$0.63$0.63-$0.61$1.40 billion$1.37 billion    
4/26/2022Q1 2022$0.58$0.60+$0.02$0.61$1.31 billion$1.34 billion    
1/26/2022Q4 2021$0.55$0.51($0.04)$0.49$1.34 billion$1.33 billion    
10/27/2021Q3 2021$0.53$0.54+$0.01$0.54$1.32 billion$1.31 billion    
7/29/2021Q2 2021$0.55$0.64+$0.09$0.50$1.29 billion$1.38 billion    
4/19/2021Q1 2021$0.47$0.54+$0.07$0.54$1.16 billion$1.22 billion  

Edwards Lifesciences Earnings - Frequently Asked Questions

When is Edwards Lifesciences's earnings date?

Edwards Lifesciences has confirmed that its next quarterly earnings data will be published on Thursday, April 25th, 2024. Learn more on EW's earnings history.

Did Edwards Lifesciences beat their earnings estimates last quarter?

In the previous quarter, Edwards Lifesciences (NYSE:EW) reported $0.64 earnings per share (EPS) to hit the analysts' consensus estimate of $0.64. Learn more on analysts' earnings estimate vs. EW's actual earnings.

How can I listen to Edwards Lifesciences's earnings conference call?

The conference call for Edwards Lifesciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Edwards Lifesciences's conference call transcript?

The conference call transcript for Edwards Lifesciences's latest earnings report can be read online. Read Transcript

How much revenue does Edwards Lifesciences generate each year?

Edwards Lifesciences (NYSE:EW) has a recorded annual revenue of $6.00 billion.

How much profit does Edwards Lifesciences generate each year?

Edwards Lifesciences (NYSE:EW) has a recorded net income of $1.40 billion. EW has generated $2.30 earnings per share over the last four quarters.

What is Edwards Lifesciences's price-to-earnings ratio?

Edwards Lifesciences (NYSE:EW) has a trailing price-to-earnings ratio of 37.59 and a forward price-to-earnings ratio of 31.32. The price/earnings-to-growth ratio is 4.32.

What is Edwards Lifesciences's EPS forecast for next year?

Edwards Lifesciences's earnings are expected to grow from $2.76 per share to $3.10 per share in the next year, which is a 12.32% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NYSE:EW) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
Biden’s $374B Giveaway Into This Sector
DTI
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Urgent alert: open this for a huge profit potential
Timothy Sykes
How Biden has already won 2024
Porter & Company
Top 5 AI Stocks to Buy for 2024
Market Moving Trends